Department of General Surgery, Peking Union Medical College Hospital, Beijing, China.
Department of Medical Insurance, Peking Union Medical College Hospital, Beijing, China.
J Robot Surg. 2024 Aug 12;18(1):320. doi: 10.1007/s11701-024-02075-6.
Robotic surgery has been increasingly adopted in various surgical fields, but the cost-effectiveness of this technology remains controversial due to its high cost and limited improvements in clinical outcomes. This study aims to explore the health economic implications of robotic pancreatic surgery, to investigate its impact on hospitalization costs and consumption of various medical resources. Data of patients who underwent pancreatic surgery at our institution were collected and divided into robotic and traditional groups. Statistical analyses of hospitalization costs, length of stay, costs across different service categories, and subgroup cost analyses based on age, BMI class, and procedure received were performed using t tests and linear regression. Although the total hospitalization cost for the robotic group was significantly higher than that for the traditional group, there was a notable reduction in the cost of medical consumables. The reduction was more prominent among elderly patients, obese patients, and those undergoing pancreaticoduodenectomy, which could be attributed to the technological advantages of the robotic surgery platform that largely facilitate blood control, tissue protection, and suturing. The study concluded that despite higher overall costs, robotic pancreatic surgery offers significant savings in medical consumables, particularly benefiting certain patient subgroups. The findings provide valuable insights into the economic viability of robotic surgery, supporting its adoption from a health economics perspective.
机器人手术已在多个外科领域得到广泛应用，但由于其高昂的成本和对临床结果改善有限，该技术的成本效益仍存在争议。本研究旨在探讨机器人胰腺手术的健康经济学意义，以研究其对住院费用和各种医疗资源消耗的影响。收集了在我院行胰腺手术的患者数据，并分为机器人组和传统组。使用 t 检验和线性回归对住院费用、住院时间、不同服务类别成本以及基于年龄、BMI 类别和手术类型的亚组成本分析进行了统计学分析。尽管机器人组的总住院费用明显高于传统组，但医疗耗材的成本却显著降低。在老年患者、肥胖患者和接受胰十二指肠切除术的患者中，降低更为明显，这可能归因于机器人手术平台的技术优势，其在很大程度上有利于控制出血、保护组织和缝合。研究得出结论，尽管整体成本较高，但机器人胰腺手术在医疗耗材方面可显著节省成本，尤其有益于某些特定患者群体。这些发现为机器人手术的经济可行性提供了有价值的见解，从健康经济学角度支持其采用。
